Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"

N/AUnknownNCT01976468

University of Zurich100 enrolled

Overview

The investigators hypothesize that a low number of SCC in OTR will metastasize.

In a large international multicenter prospective observational study a total number of 1000 OTR (organ transplant recipients) with a histologically proven cutaneous SCC (squamous cell carcinoma) will be included in 10 centers and followed during 2 years to establish the cumulative incidence of metastases in OTR with cutaneous SCC.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Squamous Cell Carcinoma

Interventions

SCC metastasisOTHER

occurrence of SCC metastasis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * Organ-transplant recipients (OTR). * Histologically proven cutaneous invasive SCC at time of inclusion Exclusion criteria: * Lack of consent. * History of metastases of cutaneous SCC

Locations (2)

Leiden University Medical Center

Leiden, Netherlands

University Hospital Zurich, Division of Dermatology

Zurich, Canton of Zurich, Switzerland

Outcomes

Primary Outcomes

SCC metastasis detection

Time frame: two years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.